# A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With Rhinitis

> **NCT00464568** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 32 (actual)

## Conditions studied

- Rhinitis, Allergic, Seasonal

## Interventions

- **DRUG:** GSK256066

## Key facts

- **NCT ID:** NCT00464568
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03-28
- **Primary completion:** 2007-05-16
- **Final completion:** 2007-05-16
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00464568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00464568, "A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With Rhinitis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00464568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*